Next Generation News and Research

RSS

Medivir reports net sales of SEK 698.6M for fiscal 2011

Today, Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, is publishing its Interim Report for the period 1 January - 31 December and its operational report for the fourth quarter of 2011.

23 Feb 2012

Accelitech embarks on a proton cancer therapy project

Accelitech LLC, the leader in the development and full-cycle management of technology-driven cancer treatment programs, is pleased to announce its inaugural proton therapy project. The treatment center project, now under development, is the latest in Accelitech's ongoing effort to bring leading treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.

23 Feb 2012

First-ever comparative analysis of antimalarial medicines at every step of the parasite's life cycle

MMV and partners have completed the first-ever comparative analysis of all currently available and in-development antimalarials in terms of the steps they target in the parasite's lifecycle. This information provides the missing pieces of the puzzle needed to develop future medicines able to block transmission of the parasite from person to person.

23 Feb 2012

Dyax fourth quarter total revenues decrease to $8.5 million

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2011.

22 Feb 2012

CardioNet fourth quarter revenue decreases 6.6% to $26.8 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the fourth quarter and full year-ended December 31, 2011.

22 Feb 2012

Academic and industry leaders team up to develop next generation medical imaging technology

For over a decade, GE Healthcare has partnered with academic researchers from Purdue, Notre Dame and Michigan, and experts from Intel, to develop Veo – the world’s first Model-Based Iterative Reconstruction (MBiR) technique. Available on GE’s Discovery CT750 HD, Veo changes the rules of CT imaging by helping physicians provide accurate diagnoses with high quality images while enabling them to lower patients’ radiation dose levels.

22 Feb 2012

Researchers discover new evidence on how cholesterol transfers from HDLs to LDLs

Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have found new evidence to explain how cholesteryl ester transfer protein (CETP) mediates the transfer of cholesterol from "good" high density lipoproteins (HDLs) to "bad" low density lipoproteins.

21 Feb 2012

Xencor, Boehringer Ingelheim partner to develop and supply biosuperior monoclonal antibodies

Xencor, Inc., a company using its proprietary Protein Design Automation (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal antibodies.

21 Feb 2012

ZirMed launches VeraFund Manager for healthcare providers

ZirMed, a preeminent provider of revenue cycle and information solutions for healthcare, today announced the launch of VeraFund Manager for healthcare providers. Available exclusively from ZirMed and utilizing advanced payment and remittance processing support from BNY Mellon, the service delivers an end-to-end automated patient/payer solution for healthcare providers.

20 Feb 2012

Evolution of cancer genome to be discussed at 2012 AAAS annual meeting

Professor Mike Stratton, Director of the Wellcome Trust Sanger Institute, will speak about 'the evolution of the cancer genome' at the prestigious 2012 American Association for the Advancement of Science annual meeting. The AAAS annual meeting is one of the world's most widely recognized science events.

19 Feb 2012

NASA awards Endeavor Fellowship to Arizona teacher

Sandra Trevino, a teacher at Buena High School, Sierra Vista, Arizona, has been awarded an Endeavor Fellowship with the National Aeronautics and Space Administration (NASA). NASA's Endeavor Science Teaching Certificate Project provides live, online training for educators working to earn a STEM (science, technology, engineering, mathematics) certificate from Teachers College, Columbia University, N.Y.

18 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

HeartWare revenues for fiscal 2011 increase to $82.8 million

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced revenue of $23.1 million for the fourth quarter ended December 31, 2011, as compared to $20.9 million for the fourth quarter of 2010.

16 Feb 2012

Alfred P. Sloan Foundation announces recipients of 2012 Sloan Research Fellowships

The Alfred P. Sloan Foundation is pleased to announce the selection of 126 outstanding U.S. and Canadian researchers as recipients of Sloan Research Fellowships for 2012. Awarded annually since 1955, the fellowships are given to early-career scientists and scholars whose achievements and potential identify them as rising stars, the next generation of scientific leaders.

16 Feb 2012

Oxford Gene Technology develops optimised rare disease sequencing and analysis service

Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house technical or bioinformatics expertise.

From Oxford Gene Technology 16 Feb 2012

Greenest supercomputer to advance study of human disease

Victoria will be home to one of Australia's fastest supercomputers and the world's greenest supercomputer, the IBM Blue Gene/Q, which will be housed at the Victorian Life Sciences Computation Initiative (VLSCI) hosted by the University of Melbourne, and is aimed at advancing the study of human disease.

15 Feb 2012

Gene sequencing could identify genetic variants of lung cancer and colorectal cancer

Foundation Medicine Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute have come up with the results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.

14 Feb 2012

New software key for personalized cancer medicine

High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients.

14 Feb 2012

Fluidigm announces availability of Access Array Barcode Library for Ion Torrent PGM

Fluidigm Corporation today announced the availability of the Access Array Barcode Library for the Ion Torrent Personal Genome Machine (PGM) sequencer. This barcode library allows multiplexing of up to 96 different samples in a single sequencing run.

13 Feb 2012

Discovery of novel rearrangements and fusions supports role for NGS in treatment of cancer

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer gene analysis to routine clinical care, and Dana-Farber Cancer Institute today announced the Nature Medicine publication of results from their collaborative next-generation sequencing (NGS) study to assay cancer-relevant genes in 24 non-small cell lung cancer (NSCLC) and 40 colorectal cancer (CRC) cases.

13 Feb 2012

Next Generation News and Research

Medivir reports net sales of SEK 698.6M for fiscal 2011

Accelitech embarks on a proton cancer therapy project

First-ever comparative analysis of antimalarial medicines at every step of the parasite's life cycle

Dyax fourth quarter total revenues decrease to $8.5 million

CardioNet fourth quarter revenue decreases 6.6% to $26.8 million

Academic and industry leaders team up to develop next generation medical imaging technology

Researchers discover new evidence on how cholesterol transfers from HDLs to LDLs

Xencor, Boehringer Ingelheim partner to develop and supply biosuperior monoclonal antibodies

ZirMed launches VeraFund Manager for healthcare providers

Evolution of cancer genome to be discussed at 2012 AAAS annual meeting

NASA awards Endeavor Fellowship to Arizona teacher

FDA approves Medtronic's Resolute Integrity DES to treat CAD

HeartWare revenues for fiscal 2011 increase to $82.8 million

Alfred P. Sloan Foundation announces recipients of 2012 Sloan Research Fellowships

Oxford Gene Technology develops optimised rare disease sequencing and analysis service

Greenest supercomputer to advance study of human disease

Gene sequencing could identify genetic variants of lung cancer and colorectal cancer

New software key for personalized cancer medicine

Fluidigm announces availability of Access Array Barcode Library for Ion Torrent PGM

Discovery of novel rearrangements and fusions supports role for NGS in treatment of cancer

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News